Samsung Medical Center
Hodgkin's lymphoma treatment cost in Republic of Korea typically starts with a consultation with a hematologist, which runs from $100 to $300. Primary treatment involving chemotherapy ranges from $2,800 to $8,500, depending on the staging and necessary drug protocols. Expenses are influenced by the choice of immunotherapy, radiotherapy sessions, and whether bone marrow transplantation is required. Patients can expect approximately 70-85% savings compared to the US, with top care centered in Seoul.
Typical Hodgkin's lymphoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, patients should prioritize JCI-accredited facilities like Severance Hospital or SNUBH. These centers utilize digital BESTcare systems to coordinate multidisciplinary oncology protocols efficiently. Samsung Medical Center is ideal for those requiring presidential-standard care and state-of-the-art IGRT technology. Asan Medical Center offers the highest multidisciplinary volume, making it the best choice for patients needing complex organ-related support during intensive chemotherapy.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Chemotherapy | from $2,800 | from $2,430 | from $2,500 |
| Immunotherapy with Keytruda (Pembolizumab) | from $5,200 | from $3,300 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Biological therapy | - | from $5,500 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.
The doctor is the Director of the Yonsei Cancer Center at Yonsei University Health System in Seoul, South Korea. Specializing in the treatment of advanced gastric cancer, the doctor has extensive expertise in surgery, oncology, and gastroenterology.
The doctor has held prestigious positions such as President of the Korean Gastric Cancer Association and the International Gastric Cancer Association, and Chairman of the Board of the Korean Cancer Association and the Korean Surgical Society.
Recognized as an outstanding surgeon in gastric cancer surgery, the doctor has received numerous accolades, including the Cancer Academic Award and the Yuhan Academic Award.
The doctor heads the Division of Hematology-Oncology and graduated from Seoul National University College of Medicine.
Specializes in lung cancer, head and neck cancer, and esophageal cancer. Holds memberships in several prestigious organizations, including the Korean Medical Association, American Society of Clinical Oncology, and the European Society of Medical Oncology.
The doctor is a highly experienced Hematologist-Oncologist with over 26 years of expertise in the field. Specializing in the treatment of colon cancer, hematological oncology, myelomas, and lymphoma, the doctor is proficient in advanced procedures such as Bone Marrow Transplantation, including Alternate Donor and Mismatched Transplants.
With a strong academic background, the doctor holds an M.D. from Yonsei University College of Medicine and a Ph.D. from Sungkyunkwan University College of Medicine. The doctor is also a member of multiple professional societies and has contributed to the field through numerous paper publications.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Primary treatment for Hodgkin lymphoma in South Korea involves specialized chemotherapy and targeted radiation therapy. Top Seoul centers offer advanced immunotherapy with pembrolizumab and high-dose chemotherapy alongside stem cell transplants. Accreditation by JCI and KOIHA ensures these protocols meet international safety and excellence standards for hematologic care.
Bookimed Expert Insight: South Korea's cancer centers operate at extreme efficiency, with Asan Medical Center performing over 65,000 operations annually. This high volume across Seoul centers allows multidisciplinary teams to manage complex oncology cases that many general hospitals elsewhere might see only occasionally. Patients benefit from this collective institutional experience in managing specific lymphoma subtypes.
Patient Consensus: Patients emphasize the need to work with dedicated lymphoma specialists rather than general oncologists for precise staging. They often note that Korean oncology teams provide very structured care involving frequent imaging and rigorous blood monitoring during treatment.
Autologous and allogeneic stem cell transplants are available at major South Korean oncology centers for Hodgkin's lymphoma. Autologous transplants use the patient's own cells after intensive therapy. Allogeneic procedures require HLA-matched donors. Tertiary hospitals in Seoul provide these sophisticated hematologic treatments within JCI-accredited facilities.
Bookimed Expert Insight: Asan Medical Center performs over 65,000 operations annually and conducts 45% of Korea's heart transplants. This high surgical volume across specialties suggests a highly developed infrastructure for complex transplants. Patients should prioritize these high-capacity centers where multidisciplinary teams manage post-transplant recovery and immune response monitoring.
Patient Consensus: Patients note that autologous transplants are the routine path after initial relapses. They emphasize that while facilities are widely available, eligibility depends heavily on achieving remission and maintaining strong organ function before the procedure.
Republic of Korea hosts top-tier facilities for Hodgkin's lymphoma including Samsung Medical Center, Asan Medical Center, and Severance Hospital. These Seoul-based institutions provide advanced multidisciplinary oncology care. They utilize diagnostic tools like sentinel lymph node biopsy and PET-CT for precise cancer staging.
Bookimed Expert Insight: While prestige is high across Seoul, Asan Medical Center and Samsung Medical Center handle the largest patient volumes. Asan manages over 180,000 yearly cases, suggesting deeper clinical experience. Patients should prioritize clinics with KOIHA accreditation to ensure they meet strict national quality standards.
Patient Consensus: Patients note it is vital to bring existing biopsy slides and imaging to Seoul. This helps the hematology-oncology teams speed up pathology reviews and treatment planning.
Foreign patients can participate in clinical trials in Republic of Korea. Eligibility depends on specific study protocols and logistical feasibility. Large university hospitals like Samsung Medical Center host most oncology trials. Patients must meet strict criteria. These include treatment history and the ability to stay for long-term follow-up.
Bookimed Expert Insight: Samsung Medical Center serves over 2 million patients annually. Their Comprehensive Cancer Center helps manage massive patient volumes. While trials are technically open, logistics often decide participation. Patients should prioritize clinics with Joint Commission International accreditation. These facilities usually have more experience coordinating with international research sponsors.
Patient Consensus: Patients note it is easier to get accepted for standard care than trials. Ongoing monitoring and visa limits make long-term study participation physically demanding.
Professional medical interpretation is highly recommended for Hodgkin's lymphoma treatment in South Korea. While many leading hospitals employ English-speaking staff, complex oncology discussions regarding chemotherapy response or staging require precise terminology. Most JCI-accredited facilities in Seoul provide dedicated interpretation to ensure patient safety and informed consent.
Bookimed Expert Insight: While major centers like Asan Medical Center or Samsung Medical Center serve over 1,500,000 patients annually, high volume can limit a doctor's time. Relying on an interpreter ensures your specific questions about complex treatments like Keytruda are addressed efficiently during rounds. This is especially vital in Korean oncology, where hospital stays are common during initial chemotherapy cycles.
Patient Consensus: Patients note that while basic English works for simple tasks, professional help is essential when debating treatment plans. Many suggest confirming interpreter availability before your first oncology appointment to avoid confusion about critical test results.
Major Korean hospitals accept international insurance, provided they have a dedicated international clinic. High-volume tertiary centers like Severance Hospital and Asan Medical Center handle direct billing for major providers. Most smaller clinics require upfront payment followed by a later reimbursement claim.
Bookimed Expert Insight: South Korea ranks 6th globally on Bookimed for service volume, reflecting its efficiency in handling international patients. Large centers like Seoul National University Hospital are fully digitalized to accelerate paperwork. Our data shows that while these hospitals treat over 10,000 daily patients, insurance verification still takes time. Patients should share policy details 2 weeks early to avoid delays in starting Hodgkin's lymphoma protocols.
Patient Consensus: Patients note that even with insurance, paying upfront is common, so keeping every receipt is vital. Many emphasize that having a hospital with a dedicated international patient center makes the reimbursement process much smoother.